Skip to main content

News

Publication
Dec 2, 2024

Nature Reviews Drug Discovery: Antiviral target compound profile for pandemic preparedness

This article presents a recommended Antiviral Target Compound Profile (TCP) developed by the INTREPID Alliance. The TCP is designed to accelerate the development of and facilitate global access to antivirals targeting pandemic-potential pathogens.

Read more
Funding
Nov 22, 2024

2026 NIAID DMID Omnibus Broad Agency Announcement (BAA)

NIAID seeks proposals to advance the research and development of innovative candidate therapeutics, vaccines, and diagnostics for antimicrobial-resistant (AMR) pathogens and viruses with pandemic potential.

Read more
Press Release
Oct 22, 2024

INTREPID Alliance Appoints Scientific Advisory Board to Drive Antiviral Research and Protect Global Public Health

Renowned experts in virology, immunology, and drug development will help guide INTREPID’s efforts to accelerate breakthrough antiviral therapies for emerging viral pandemic agents

Read more
Press Release
Oct 9, 2024

New INTREPID Alliance Antiviral Landscape Report Highlights Urgent Need to Bolster R&D Pipeline in Support of Global Pandemic Preparedness Efforts

Current mpox outbreak underscores gaps in access to medical countermeasures to help mitigate the severity of future outbreaks

Read more
Press Release
Apr 29, 2024

INTREPID Alliance Landscape of Promising Antivirals in Clinical Development Reveals Gaps in Global Defense Against Potential Future Pandemics

Detailed scientific analysis of antiviral pipeline identifies most promising clinical compounds aligned with 100 Days Mission global preparedness recommendations

Read more
Event
Apr 22, 2024

Is the World Ready for an Arbovirus Epidemic?

The Chair of the INTREPID Alliance’s Scientific Advisory Board, Dr. Ruxandra Draghia-Akli, delivered remarks at the opening session of the International Arbovirus Summit hosted by GISAID and the Ministries of Health for Brazil and Indonesia.

Read more
Press Release
Jan 24, 2024

INTREPID Alliance Releases Review of Antiviral Compounds in Clinical Development to Contribute to Collaborative Efforts in Pandemic Preparedness

Global landscape analysis identifies strengths and gaps in R&D pipeline to inform international pandemic preparedness efforts

Read more
Statement
Sep 20, 2023

Accelerating antiviral development is central to pandemic preparedness

As leaders and health experts from across the world gather in New York for the UN General Assembly, they will be considering three issues that are critical to the future of global health and global health security.

Read more
In the News
Aug 2, 2023

INTREPID’s new strategy to help build a pandemic war chest

The INTREPID Alliance has abandoned its fundraising plans, but not its mission to expedite antiviral development for future pandemics.

Read more
In the News
Jul 26, 2023

New Industry Group Seeking Out Antiviral Candidates For Future Pandemics

An alliance of seven R&D-based pharma firms is putting collaboration and partnerships at the center of the search for new antivirals against emerging pathogens.

Read more
Press Release
Jul 20, 2023

Pharmaceutical companies come together to accelerate the development of innovative antiviral treatments in preparation for future pandemics

Seven innovative pharmaceutical companies have established the INTREPID Alliance, with the goal of accelerating progress in discovery and development of new antiviral treatments for future pandemics.

Read more